ArticleCell discovery2020
CG14906 (mettl4) mediates m
Abstract read
In one paragraph
Article in Cell discovery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.
0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed.
- METTL4 enhances GLI1 translation through mJournal of advanced research · 2026Article
- Role of the m6A methyltransferase Mettl16 in Drosophila development.PLoS genetics · 2026Article
- Engineering Bisubstrates to Target mChemistry (Weinheim an der Bergstrasse, Germany) · 2026Article
- METTL4 regulates synaptic UCP2 N6-adenosine methylation to mediate pain hypersensitivity in female mice.Cellular and molecular life sciences : CMLS · 2025Article
- Mechanism for the substrate recognition by a eukaryotic DNA NNature communications · 2025Article
- Targeting NHypertension (Dallas, Tex. : 1979) · 2025Article
- SSB cooperates with METTL16-mediated mCell reports · 2025Article
- Prognosis model of patients with breast cancer based on metabolism-related LncRNAs.Discover oncology · 2025Article
- The novel roles of RNA m6A modification in regulating the development, infection, and oxidative DNA damage repair of Phytophthora sojae.PLoS pathogens · 2024Article
- Comprehensive analysis of transcriptome-wide MEpigenetics · 2023Article
- Randomly incorporated genomic N6-methyldeoxyadenosine delays zygotic transcription initiation in a cnidarian.The EMBO journal · 2023Article
- CRISPR-Cas9-Mediated Mutation of Methyltransferase METTL4 Results in Embryonic Defects in SilkwormInternational journal of molecular sciences · 2023Article
- Regulation of Gene Expression by m6Am RNA Modification.International journal of molecular sciences · 2023Review
- Comprehensive analysis of a novel RNA modifications-related model in the prognostic characterization, immune landscape and drug therapy of bladder cancer.Frontiers in genetics · 2023Article
- Structural insights into molecular mechanism for NNature communications · 2022Article
- The role of N6-methyladenosine-modified non-coding RNAs in the pathological process of human cancer.Cell death discovery · 2022Review
- Means, mechanisms and consequences of adenine methylation in DNA.Nature reviews. Genetics · 2022Review
- Bacterial N4-methylcytosine as an epigenetic mark in eukaryotic DNA.Nature communications · 2022Article
- Evolutionary History of RNA Modifications at N6-Adenosine Originating from the R-M System in Eukaryotes and Prokaryotes.Biology · 2022Article
- N6-methyladenine: A Rare and Dynamic DNA Mark.Advances in experimental medicine and biology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Lei Gu *Department of Medicine, Division of Newborn Medicine and Epigenetics Programe, Boston Children's Hospital, Boston, MA 02115 USA.ORCID 0000-0001-6469-9568
Longfei Wang *Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115 USA.
Hao Chen *Department of Medicine, Division of Newborn Medicine and Epigenetics Programe, Boston Children's Hospital, Boston, MA 02115 USA.
Jiaxu Hong *Department of Ophthalmology and Vision Science, Shanghai Eye, Ear, Nose and Throat Hospital, Fudan University, 200031 Shanghai, China.
Zhangfei ShenDepartment of Medicine, Division of Newborn Medicine and Epigenetics Programe, Boston Children's Hospital, Boston, MA 02115 USA.
Abhinav DhallDepartment of Medicine, Division of Newborn Medicine and Epigenetics Programe, Boston Children's Hospital, Boston, MA 02115 USA.
Taotao LaoDivision of Rheumatology, Allergy and Immunology, Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Charlestown, MA 02129 USA.
Chaozhong LiuDepartment of Medicine, Division of Newborn Medicine and Epigenetics Programe, Boston Children's Hospital, Boston, MA 02115 USA.
Zheng WangDepartment of Medicine, Division of Newborn Medicine and Epigenetics Programe, Boston Children's Hospital, Boston, MA 02115 USA.
Yifan XuDepartment of Medicine, Division of Newborn Medicine and Epigenetics Programe, Boston Children's Hospital, Boston, MA 02115 USA.
Hong-Wen TangDepartment of Genetics, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115 USA.
Damayanti ChakrabortyDepartment of Medicine, Division of Newborn Medicine and Epigenetics Programe, Boston Children's Hospital, Boston, MA 02115 USA.
Jiekai ChenCAS Key Laboratory of Regenerative Biology, Joint School of Life Sciences, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou Medical University, Guangzhou, Guangdong 510530 China.
Zhihua LiuDepartment of Neurobiology, Harvard Medical School, Boston, MA 02115 USA.
Dragana RoguljaDepartment of Neurobiology, Harvard Medical School, Boston, MA 02115 USA.
Norbert PerrimonDepartment of Genetics, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115 USA.
Hao WuDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115 USA.
Yang ShiDepartment of Medicine, Division of Newborn Medicine and Epigenetics Programe, Boston Children's Hospital, Boston, MA 02115 USA.
Funding
Training in the Molecular Biology of Neurodegeneration and Alzheimer's DiseaseT32AG000222 · NIA · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI Bruce A YANKNER · 1992 to 2026
$18.5MNIA NIH HHS T32 AG000222
Abstract
PubMed holds no abstract for this paper.
Indexed as
DNA methylationTranscriptional regulatory elements
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.